DEY^® Press Releases

If you are a member of the media and would like more information about DEY, L.P., please contact our media line at 1-800-755-5560, Extension 8363.

Florida EMS and Fire Vehicles to Stock Cyanokit® 5g (hydroxocobalamin for injection) ANTIDOTE (“Cyanokit”) for Cyanide Poisoning May 29, 2008 Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone May 20, 2008 Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation May 20, 2008 Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients May 20, 2008 Clinical Trial Data for Perforomist™ Inhalation Solution to be Presented at ATS on May 20, 2008 May 16, 2008 Dey, L.P. Settles State of Alabama Pricing Litigation January 9, 2008 Dey, L.P. Partners with COPD Foundation in Support of National Heart, Lung and Blood Institute (NHLBI)’s COPD Learn More Breathe Better Awareness Campaign November 28, 2007

Two Clinical Trials for Nebulized Formoterol Fumarate On Long-Term and Cardiovascular Safety in Treating COPD October 24, 2007 Data from Three Clinical Trials for Perforomist™ Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007 October 16, 2007 Mylan Inc. subsidiary, Dey, L.P., announces that Perforomist™ (Formoterol Fumarate) Inhalation Solution is now Available for Maintenance Treatment of COPD October 08, 2007 Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR™ (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma September 27, 2007

FDA Approves ZYFLO CR™ (Zileuton) Extended-Release Tablets for Critical Therapeutics, DEY Marketing Partner for Chronic Treatment of Asthma May 31, 2007

Clinical Trial Data for Perforomist™ (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference May 20, 2007

FDA Approves Dey, L.P.'s Perforomist™ (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD May 10, 2007

Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies May 7, 2007

Dey, L.P. Reaches Settlement with Commonwealth of Massachusetts on Pricing Litigation April 24, 2007

Dey, L.P. Reaches Settlement with State of Nevada on Pricing Litigation March 29, 2007

Cyanokit® 5 g (hydroxocobalamin for injection) ANTIDOTE, A New Treatment for Cyanide Poisoning, Now Available in the United States March 29, 2007

Dey, L.P. Reaches Settlement with State of Hawaii on Pricing Litigation March 21, 2007

Critical Therapeutics and Dey, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products March 14, 2007

FDA Approves Cyanokit® for Treatment of Cyanide Poisoning December 15, 2006

Dey, L.P. Reaches Settlement with State of Ohio on Pricing Litigation November 28, 2006

Dey, L.P. Reaches Settlement with State of Idaho on Pricing Litigation November 14, 2006

Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice September 11, 2006

Dey, L.P. Reaches Settlement with State of Missouri on Pricing Litigation April 25, 2006

Dey, L.P. Names Christy Taylor New SVP for Sales, Marketing and Business Development February 14, 2006

DEY, L.P. Donates $150,000 for Napa Valley Flood Relief January 12, 2006

Merck KGaA Names Engle New Generics Group Regional Director, North America January 5, 2006

World COPD Day: 12 Million Americans Unaware They Are At Risk for Fourth Leading Cause of Death November 16, 2005

DEY, L.P. Donates $100,000 and Medications for Hurricane Katrina Disaster Relief September 14, 2005

Dey, L.P. Reaches Settlement with State of Connecticut on Pricing Litigation July 21, 2005

DEY, L.P. Continues its Strategy Toward Branded Pharmaceutical Products June 29, 2005

Napa Chamber of Commerce Names DEY, L.P. Business of the Year January 14, 2005

DEY, L.P. Donates $100,000 to the American Red Cross Tsunami Disaster Relief Effort January 03, 2005

DEY, L.P. Applauds President Bush for Signing Legislation That Will Ensure Students Can Carry Their EpiPens® With Them During the School Day November 04, 2004

Dey Recognizes California Legislators and the Governor for New Laws Protecting Students with Severe Allergies and Asthma September 30, 2004

NECA's COPD Patient Needs Assessment Survey Presented at American Thoracic Society May 25, 2004

Dey, L.P. Reaches Settlement with State of West Virginia on Pricing Litigation May 13, 2004

Statement from DEY, L.P. Regarding Pricing Litigation Mar 18, 2004

Dey, L.P. Granted Patent for AccuNeb®, Pediatric Asthma Medication March 16, 2004

Dey, L.P. Co-Sponsors First Patient COPD Education Day with COPD Resource Network November 24, 2003

Dey, L.P. Raises Over $101,000 for the American Lung Association’s “Blow the Whistle on Asthma” Walk, Leads Nation for Second Consecutive Year November 06, 2003

Dey, L.P. Granted Patent for DuoNeb®, COPD Medication October 29, 2003

Commendation from John L. Kirkwood, President and CEO, American Lung Association, for Dey's extraordinary contribution to ALA's "Blow the Whistle on Asthma" Walk. October 02, 2003

Merck Ltd., Japan Launches EpiPen® August 22, 2003

Statement from DEY LP on Settlement of Texas Litigation Jun 11, 2003

DEY, L.P. Names John Kling as Senior Vice President to Head Legal Affairs March 20, 2003

Dey, L.P., Names Al Erario as New Vice President of Quality Systems December 12, 2002

DEY L.P. Provides $25,000 Grant to National Emphysema/COPD Association November 07, 2002

DEY, L.P. Raises $71,500 For the American Lung Association’s “Blow the Whistle on Asthma” Walk November 04, 2002

Merck KGaA's U.S. Affiliate Dey Names Mel Engle as New President and CEO October 17, 2002

Dey, L.P., Names Christy Taylor as New Vice President of Sales September 16, 2002

ABCs of Back to School With Food Allergies August 05, 2002

Dey, L.P., Announces the Curosurf® Patient Assistance Program May 31, 2002

Curosurf® Offers Rapid Onset of Action and Reduced Frequency of Dosing in Treatment of Respiratory Distress Syndrome in Preterm Infants May 06, 2002

Dey Adds New Vice President of Marketing, Focuses on Product Portfolio April 25, 2002

< Back to Press Room